Cervical Intraepithelial Neoplasia
Research from N.W.J. Bulkmans and co-researchers in the area of cervical intraepithelial neoplasia published
Published in Women's Health Weekly, January 10th, 2008
"Background Tests for the DNA of high-risk types of human papillornavirus (HPV) have a higher sensitivity for cervical intraepithelial neoplasia grade 3 or worse (CIN3+) than does cytological testing, but the necessity of such testing in cervical screening has been debated. Our aim was to determine whether the effectiveness of cervical screening improves when HPV DNA testing is implemented," scientists in Netherlands report.
"Methods Women aged 29-56 years who were participating in the regular cervical screening programme in the Netherlands were randomly assigned to combined cytological and HPV DNA testing or to conventional cytological testing only. After 5 years,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Anthracyclines improve survival in HER2-positive breast cancer patients - Breast Cancer
Bevacizumab found to improve survival for patients with advanced breast cancer - Breast Cancer
Chemotherapy and tamoxifen reduce risk of second breast cancer - Breast Cancer
Ireland Cancer Center researcher finds standard treatment for breast cancer not followed - Breast Cancer
Reconstruction surgery rarely discussed with breast cancer patients - Breast Cancer
Taxol with avastin produces noteworthy results - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
